Claim 50% Off TipRanks Premium and Invest with Confidence
- Unlock hedge-fund level data and powerful investing tools designed to help you make smarter, sharper decisions
- Stay ahead of the market with the latest news and analysis so your portfolio is always positioned for maximum potential
Paragon Care Limited ( (AU:PGC) ) has provided an update.
Paragon Care Limited reported robust financial results for FY25, with revenue reaching $3.61 billion, an 8.3% increase, and an underlying EBITDA of $95.2 million, up 3.0%. The company’s successful integration of CH2 Holdings and Oborne has positioned it for long-term growth, with significant sales growth in wholesale and contract logistics. The launch of new business units in aesthetics, dental, and robotics further strengthens its market position, while the streamlined operations and centralized services platform are expected to support scalable growth and consistent performance.
The most recent analyst rating on (AU:PGC) stock is a Hold with a A$0.50 price target. To see the full list of analyst forecasts on Paragon Care Limited stock, see the AU:PGC Stock Forecast page.
More about Paragon Care Limited
Paragon Care Limited is a leading healthcare wholesaler, distributor, and manufacturer operating throughout the Asia Pacific region. The company focuses on a diverse range of healthcare products and services, including medical consumables, clinical manufacturing, and contract logistics, with a strong emphasis on innovation in areas such as aesthetics, dental, and robotics.
Average Trading Volume: 534,400
Technical Sentiment Signal: Buy
Current Market Cap: A$662.1M
For an in-depth examination of PGC stock, go to TipRanks’ Overview page.